⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Quant Flexi Cap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Quant MF | HDFC MF |
| Category | Equity - Flexi Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹114.73 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Sandeep Tandon | Nikhil Mathur |
| Inception | 07 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | 3.09% | 22.64% |
| 3Y | 15.14% | 30.41% |
| 5Y | 13.56% | — |
| Since Inception | 17.85% | 29.15% |
| Risk | ||
| 17.16 | 14.07 | |
| 1.09 | 0.59 | |
| 0.50 | 1.59 | |
| 4.43 | 21.67 | |
| 1.07 | 3.48 | |
| -10.33% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.07% | 1.03% |
| Exit Load | 1% on or before 15D, Nil after 15D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹250 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Quant MF96%
HDFC MF96%
4.0%Only 4.0% of holdings by weight are common between Quant MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingQuant MFHDFC MF
Glenmark Pharmaceuticals Ltd.3.44%2.09%
Divi's Laboratories Ltd.1.96%9.39%
Category context: Equity vs Equity. Open the full Screener →